Two cases of bullous pemphigoid effectively treated with oral tofacitinib

Soundos Youssef; Stephanie Gallitano; Lindsey A Bordone

doi:10.1016/j.jdcr.2022.10.028

Two cases of bullous pemphigoid effectively treated with oral tofacitinib

JAAD Case Rep. 2022 Nov 4:32:77-80. doi: 10.1016/j.jdcr.2022.10.028. eCollection 2023 Feb.

Authors

Soundos Youssef¹, Stephanie Gallitano², Lindsey A Bordone²

Affiliations

¹ Postdoctoral Research Fellow, Department of Dermatology, Columbia University Irving Medical Center, New York, New York.
² Assistant Professor, Department of Dermatology, Columbia University Irving Medical Center, New York, New York.

No abstract available

Keywords: BP, bullous pemphigoid; JAK inhibitor; JAK, Janus kinase; JAKi, Janus kinase inhibitor; Janus kinase inhibitor; STAT, signal transducers and activators of transcription; bullous pemphigoid; tofacitinib; treatment efficacy.

Publication types

Case Reports